Professional Documents
Culture Documents
k16 - Hipertensi Dalam Kehamilan (RHR)
k16 - Hipertensi Dalam Kehamilan (RHR)
Report on the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (AJOG Vol 183:S1, July 2000) HIPERTENSI GESTASIONAL : DIDAPATKAN DESAKAN DARAH 140/90 mmHg PERTAMA KALINYA PD KEHAMILAN, TDK DISERTA DGN PROTEINURIA DAN DESAKAN DARAH KEMBALI NORMAL < 12 MGG PASCA
PERSALINAN
PREECLAMSIA :
KRITERIA MINIMUM
DESKAN DARAH 140/90 mmHg UMUR KEHAMILAN 20 MGG, DISERTAI PROTEINURIA 300 mg/24 JAM ATAU DIPSTICK 1 + ECLAMSIA KEJANG2 PADA PREECLAMPSIA DISERTAI KOMA
INTRODUCTION :
INDUCED BY PREGNANCY
DISEASE OF THEORIES
CLINICAL MANIFESTATION : HYPERTENSION WITH OR WITHOUT ORGAN DYSFUNCTION / FAILURE THIRD LEADING CAUSE OF MATERNAL MORTALITY MORTALITY RATE : 150.000 WOMEN A YEAR WORLD WIDE
INCIDENCE
PE/E : 2% - 9% OF ALL PREGNANT WOMEN
IN SEVERAL HOSPITAL IN INDONESIA
YEAR 1993 1997 HOSPITAL RSPM PERCENTAGE 5,75 AUTHOR SIMANJUNTAK J.
1996 1997
1995 1998 2000 2002
12 HOSPITALS
RS. H.S. RSHAM RSPM
0,8 - 14
13,0 7,0
TRIBAWONO A.
MEIZIA GIRSANG. E
2002
RSCM
9,17
PRIYATINI
HYDROPS FETALIS
HYDATIDIFORM MOLES URYNARY TRACT INFECTION
PATHOGENESE :
CONTROVERSION : THE DISEASE OF THEORIES
IMMUNITY, GENETIC VASC. DISEASE TROPHOBLAST INADEQUATE TROPHOB. INVASION TO SPIRAL ARTERY OF PLACENTA
IUGR
OXYDATIVE STRESS
NEUTROPHIL ACTIVATION
ENDOTHELIAL DYSFUNCTION
PLATELET ACTIVATION
ENDOTHELIAL DYSFUNCTION
CLINICAL CLASSIFICATION:
PREECLAMPSIA - MILD - SEVERE IMPENDING ECLAMPSIA ECLAMPSIA HELLP SYNDROME
MILD PREECLAMPSIA :
BP 140/90 mmHg AFTER 20 WEEKS GESTATION PROTEINURIA 300 mg/ 24 H OR 1+ DIPSTICK WITH OR WITHOUT OTHER SYMPTOMS AND SIGN
SEVERE PREECLAMPSIA
BP 160/110 mmHG PROTEINURIA 2.0 gr / 24 H OR 2 + DIPSTICK
IMPENDING ECLAMPSIA
SEVERE PREECLAMPSIA WITH : HEADACHE
EPIGASTRIC PAIN
ECLAMPSIA
SEVERE PREECLAMPSIA + CONVULSION IS THE LEADING CAUSE OF 50.000 MATERNAL MORTALITY A YEAR WOLRD WIDE 75% OCCURRED ANTEPARTUM AND 25% POST PARTUM 40% OF SEIZURES OCCUR BEFORE HOSPITALIZATION CEREBRAL HAEMORRHAGE, PULMONARY EDEMA ARE THE MOST COMMON COMPLICATION
HELLP SYNDROME
COMPLICATION OF SEVERE PREECLAMPSIA 10-15% DIRECTLY FROM PREGNANCY
MANAGEMENT OF PREECLAMPSIA
ADEQUAT AND PROPER PRENATAL CARE IDENTIFICATION OF WOMEN AT HIGH RISK EARLY DETECTION BY THE RECOGNATION OF CLINICAL SIGNS AND SYMPTOMS THE PROGRESSION OF CONDITION TO SEVERE STATE
MATERNAL AND PERINATAL OUTCOME IN WOMEN WITH MILD PREECLAMPSIA, > 36 WEEKS GESTATION ARE USUALLY
FAVOURABLE
MATERNAL AND PERINATAL OUTCOMES DEPEND ON :
MILD PREECLAMPSIA
AMBULATORY CARE
BED REST : NOT NECESSARILY
REGULAR DIET, NO SALT RESTRICTION PRENATAL VITAMIN
HOSPITAL CARE
PERSISTENT HYPERTENSION MORE THAN 2 WEEKS PERSISTENT PROTENURIA MORE THAN 2 WEEKS ABNORMAL LABORATORY TEST ABNORMAL FETAL GROWTH
OBSTETRIC MANAGEMENT
GESTATIONAL AGE < 37 WEEKS ~ SIGN AND SYMPTOM ARE NOT WORSENED MAINTAIN UNTIL TERM
GESTATIONAL AGE > 37 WEEKS ~ WAIT UNTIL THE ONSET OF LABOR ~ CERVIX IS FAVORABLE, INDUCTION OF LABOR
SEVERE PREECLAMPSIA
MEDICAL TREATMENT
OBSTETRIC MANAGEMENT :
CONSERVATIVE : ACTIVE : -
PREGNANCY 37 WEEKS
PREGNANCY 37 WEEKS
FETAL INDICATION
MATERNAL INDICATION
MEDICAL TREATMENT :
HOSPITALIZE TOTAL BED REST FLUID THERAPY : RINGER LACTATE, DEXTROSE 5%. Mg SO4 IV ANTI HYPERTENSION : HYDRALAZIN LABETALOL NIFEDIPINE : 10 20 mg / ORALLY EVERY - 1 H, MAX : 120 mg / 24 Hours DIURETIC : NOT RECOMMENDED ANTI OXYDANT : N-ACETYL CYSTEIN CORTICOSTEROID + LUNG MATURITY 34 WEEKS
OBSTETRIC MANAGEMENT
CONSERVATIVE MANAGEMENT: GOAL : TO IMPROVE INFANT OUTCOME, WITHOUT COMPROMISING THE MOTHER
ECLAMPSIA : PE + CONVULSION
BASIC MANAGEMENT :
CONTROL THE AIRWAY, BREATHING, CIRCULATION (ABC)
MEDICAL TREATMENT :
SAME AS SEVERE PREECLAMPSIA
MOTHER
HELLP SYNDROME LIVER RUPTURED PULMONARY EDEMA RENAL FAILURE ABRUPTIO PLACENTAE DIC CEREBROL VASCULER ACCIDENT IUGR
BABY
PREMATURE LABOR INTRA CRANIAL HAEMORRHAGE CEREBRAL PALSY PNEUMO THORAX IUFD
MATERNAL DEATH
DIAGNOSIS BERDASARKAN RISIKO : - RISIKO RENDAH : HIPERTENSI RINGAN TANPA DISERTAI KERUSAKAN ORGAN - RISIKO TINGGI : HIPERTENSI BERAT / HIPERTENSI RINGAN DISERTAI PERUBAHAN PATOLOGIS, KLINIS MAUPUN BIOLOGI KERUSAKAN ORGAN KRITERIA RISIKO TINGGI PD HIPERTENSI KRONIK DLM KEHAMILAN - HIPERTENSI BERAT : DESAKAN SISTOLIK 160 mmHg DAN DESAKAN DIASTOLIK 110 mmHg, SEBELUM 20 MGG KEHAMILAN
HIPERTENSI RINGAN < 20 MGG KEHAMILAN DGN : PERNAH PREECLAMPSIA UMUR IBU > 40 THN HIPERTENSI 4 THN ADANYA KELAINAN GINJAL ADANYA DIABETES MELLITUS (KLAS B KLAS F)
KARDIOMIOPATI
MEMINUMI OBAT ANTI HIPERTENSI SEBELUM HAMIL
KLASIFIKASI
NORMAL PREEHIPERTENSI HIPERTENSI STADIUM I HIPERTENSI STADIUM II
SISTOLIK (mmHg)
< 120 120 139 140 159 160
DIASTOLIK (mmHg)
< 80 80 89 90 99 110
(the 7th Report of the Joint National Committee (JNC 7) MIMs Cardiovascular Guide th. 2003 2004)
PEMERIKSAAN LABORATORIUM
PEMERIKSAAN (TEST) KLINIK SPESIALISTIK : ECG
ECHOCARDIOGRAPHY
OPHTALMOLOGY USG GINJAL
PEMERIKSAAN (TEST) LABORATORIUM FUNGSI GINJAL : CREATININE SERUM BUN SERUM, ASAM URAT, PROTEINURIA 24 JAM PEMERIKSAAN PROTEINURIA SECARA PERIODIK FUNGSI HEPAR
SETIAP BLN
BILA DICURIGAI IUGR DI MONITOR DGN NST DAN PROFIL BIOFISIK HIPERETENSI KRONIK DLM KEHAMILAN DGN PENYULIT KARDIOVASKULER ATAU PENY. GINJAL PERLU MENDAPAT
PERHATIAN KHUSUS
PENGOBATAN MEDIKAMENTOSA
mmHg
DGN DISFUNGSI ORGAN DAN DESAKAN DIASTOLIK 90 mmHg OBAT ANTIHIPERTENSI PILIHAN PERTAMA : METHYLDOPA : 0.5-3.0 g/hr, DIBAGI DLM
2-3 DOSIS.
HELLP SYNDROME
PREGNANCY
10-14% CASE
PREECLAMPSIA
HELLP SYNDROME
HELLP SYNDROME
FIRST DISCRIBED BY WEINSTEIN 1982: ACRONYM OF : H : HEMOLYSIS
EL
LP INCIDENCE :
:
:
CRITERIA DIAGNOSTIC
LABORATORY FINDING:
HEMOLYSIS ABNORMAL PERIPHERAL SMEAR : SCHISTOCYTES AND BURR CELLS TOTAL BILIRUBIN LEVEL > 1,2 mg/Dl LACTATE DEHYDROGENASE LEVEL > 600 /L
ELEVATED LIVER FUCTION SGOT LEVEL 70 / L (LDH) LACTATE DEHYDROGENASE LEVEL > 600 /L LOW PLATELET COUNT PLATELET COUNT < 100.000/m3
THE LABORATORY DIAGNOSTIC CRITERIA USED AT THE UNIVERSITY OF TENNESSEE DIVISION OF MATERNAL FETAL MEDECINE, MEMPHIS TN. WITLIN AND SIBAI (1999)
WITH : LDH 600 U/L SGOT 40 U/L CLASS II : PLATELET 50.000/m3 - < 100.000/m3 WITH : LDH 600 U/L SGOT 40 U/L
CLASS II : PLATELET 50.000/m3 - < 150.000/m3 WITH : LDH 600 U/L SGOT 40 U/L
MEDICAL MANAGEMENT
SAME AS SEVERE PREECLAMPSIA WHEN THROMBOCYTE COUNT IS < 50.000 mm3, 10 UNITS OF THROMBOCYTE OR FRESH WHOLE BLOOD MUST BE GIVEN WHEN PATIENT IS COMATOUS, SHE MUST BE TAKEN TO THE ICU WHEN THROMBOCYTE COUNTS IS < 50.000/mm3 FIBRINOGEN LEVEL, PROTHROMBINE TIME, PARTIAL THROMBOPLASTIN TIME, D-DIMMER MUST BE CHECKED TO FIND DIC
OBSTETRIC MANAGEMENT
WHEN MOTHERS IS STABLE TERMINATE THE PREGNANCY OR CONSERVATIVE MANAGEMENT. CONSERVATIVE MANAGEMENT CAN BE DONE WHEN :
COMPLICATION
THE COMPLICATIONS THAT CAN OCCUR IN HELLP SYNDROME ARE : NEUROLOGIC
CONCLUSIONS :
1. HYPERTENSION, PROTEINURIA AND OTHERS SYMPTOMS-SIGN OF PREECLAMPSIA ARE INDUCED BY PREGNANCY 2. BESIDE HYPERTENSION AND PROTEINURIA, OTHER SYNDROMA OF PREECLAMPSIA ARE EPIGASTRIC PAIN, HEADCHE, VISUAL DISTURBANCE, OLIGURIA, CONVULSION, AND RENAL FAILURE. 3. THERE ARE STILL CONTROVERSION IN CLASSIFICASION, DIAGNOSTIC AND MANAGEMENT OF PREGNANCY INDUCED HYPERTENSION.
4. IN PATIENTS WITH MULTI ORGAN DYSFUNCTION / FAILURE MULTIDISIPLIN MANAGEMENT IS NEEDED. 5. IGNORANCE, POVERTY, LATE ADMITTANCE TO HOSPITAL WILL INCREASE FERINATAL - MATERNAL, MORBIDITY AND MORTALITY
REFERENCES :
1. Baker PN., Kingdom J., Preeclampsia Current Perspectives on Management. The Parthenon Publishing Group, New York, USA, 2004 page 133 143. 2. Brown MA. Diagnosis and Classification of Preeclampsia and Hypertensive Disorders of Pregnancy in Belfort MA, Thornton S, Saade GR. Hypertension in Pregnancy, Marcel Dekker, Inc. New York, 2003, page 1 14. 3. Dekker GA, Sibai BM. Ethiology and Pathogenesis of Preeclampsia : Current Concept. AmJ Obstet Gynecol 1998; 179 : 1359 75. 4. Dikman AM, Hypertension in Pregnancy, Proposal for Clinical Practice Guide-line in Indonesia, 1st. ed. English Version, March 2005. 5. Girsang ES. Analisa Tekanan Darah dan Proteinuria sebagai Faktor Prognosi. Kematian Maternal dan Perinatal pada Preeeklamsia Berat dan Eklamia. Tesis Bagian Obgin FK. USU RSUP. H. Adam Malik / RSUD Dr. Pirngadi Medan, 2004.
6. Robert JM, Carl A Hubel Oxydative Stress in Preeclampsia. AJOG 2004 : 190 : 117 8. 7. Sibai BM; Diagnosis Prevention, and Management of Eclampsia, Obstetrics & Gynecology, vol 105, number 2, February 2005, page 405 410.
8. Sibai BM, Gus Dekker GA, Michael Kupferminc Preeclampsia Lancet 2005, 365 : 785 99.
9. Lipstein H, et al. Current Consept of Eclampsia. American Journal of Emergency Mediciene 203; 21 (3) : 233 7.
10. Norwitz ER, Robinson JN, Rifke JT. Prevention of Preeclampsia : Is it Possible ? Clin Obstet Ginecology 1999, 42 (3) 436 54.
11. Audibert F, et al. Clinical Utility of Strict Diagnostic Creteria for the HELLP (Hemolysis, Elevated Liver Enzymes, and Low Platelets) Syndorome AJOG 1996; 175 : 460 4.
12. Weinstein L, Syndrome of Haemolysis, Elevated Liver Enzymes and Low Trombocyte Count : A severe Consequense of Hypertension in Pregnancy. Am J. Obstet Gynecol 1982; 42 : 159-167.
13. James N, Martin Jr, MD, Carlh. Rose, MD, Christian M. Briery, MD. Understanding and Managing Hellp Syndrome : The Integral Role of Aggressive Glucocorticoids for Mother and Child. A Jog 2005. 08. 044.
14. Magann EF, Martin RW, Jsaacs JD, et al. Corticosteroids for the Enhancement of Fetal Lung Maturity : Impact on the Gravida with Preeclampsia and the HELLP Syndrome. Aust MZ J Obstet Gynecol 1993; 33 : 127 30. 15. Martin JN, Perry KG, Blake PG, et al. Better Maternal Outcomes are Achieved with Dexamethasone Therapy for Postpartum HELLP (Hemolysis, Elevated Liver Enzymes and Low Thrombosit Counts) Syndrome. AmJ Obstet Gynecol 1997; 177 : 1011 7. 16. Pedoman Penanganan Penderita Preeklamsia Berat dan HELLP Syndrome, Satgas Penanganan Penderita Preeklamsia Berat dan HELLP Syndrome Bagian / UPF Ilmu Kebidanan dan Penyakit Kandungan FK USU RSUD. Dr. Pirngadi Medan tahun 2002.